Keyphrases
Microvesicles
100%
Extracellular Vesicles
68%
Bladder Cancer
53%
Radical Cystectomy
39%
Escherichia Coli
38%
Exosomes
37%
Phage
30%
Robot-assisted Radical Cystectomy
30%
Receptor Antagonist
29%
Muscle-invasive Bladder Cancer
29%
Neoadjuvant Chemotherapy
28%
Meta-analysis
28%
Prostate Cancer
26%
Complement C2
24%
Oilseed Rape
24%
Arginine Deiminase
23%
Electrowetting-on-Dielectric (EWoD)
23%
Robot-assisted Laparoscopic Radical Prostatectomy
23%
Systematic Meta-analysis
22%
Clostridioides Difficile
22%
Trypanosoma Cruzi (T. cruzi)
21%
Brassica Napus
20%
Prostate Cancer Cells
20%
Peptide nucleic Acid
20%
Resistance Genes
19%
Confidence Interval
19%
Tomato
19%
Pyrenopeziza Brassicae
19%
Vesicle Release
18%
Difficile
18%
Microfluidics
18%
Microfluidic Device
18%
Spinal muscular Atrophy
17%
Botrytis Cinerea
17%
Phoma Stem Canker
17%
Robot-assisted Radical Prostatectomy
17%
Non-muscle Invasive Bladder Cancer (NMIBC)
16%
Plasma Membrane Vesicles
16%
KATP Channel
16%
Light Leaf Spot
16%
In Cancer
16%
COVID-19
15%
P. Brassicae
15%
Caenorhabditis Elegans
15%
Host Cell
15%
Chemotherapy
15%
Sclerotinia Sclerotiorum
14%
Survival Motor Neuron
14%
Elastomer
14%
Arabidopsis Thaliana
14%
Arabidopsis
14%
Prostate
14%
Ca(II)
14%
Antibiotic Resistance
14%
Oncological Outcomes
14%
High Risk
13%
Clinical Outcomes
13%
Open Radical Cystectomy
13%
Urological Cancer
13%
Cystectomy
13%
Antisense Peptide
12%
Hospital Episode Statistics
12%
Statistic Data
12%
Blood Plasma
12%
Leptosphaeria Maculans
12%
Microvesiculation
12%
Pancreatic Cells
12%
Neurovascular Unit
12%
Tumor
11%
Polygalacturonase-inhibiting Protein
11%
Microfluidic Platform
11%
Cystoscopy
11%
Radical Prostatectomy
11%
Urinary Biomarkers
11%
Antibiotics
11%
Quantitative PCR
11%
Plasma Membrane
11%
Polygalacturonase
11%
Lab-on-a-disc
11%
Receptor-interacting Protein Kinase 1 (RIPK1)
10%
PubMed
10%
COVID-19 Pandemic
10%
Surgeons
10%
Human Complement
10%
Digital Microfluidics
10%
Oxalate
10%
Binding Site
10%
Jasmonic Acid
10%
Infectious Diseases
10%
Overall Survival
10%
Transurethral Resection of Bladder Tumor (TURBT)
10%
Robotic Surgery
10%
Electrostatic Precipitation
10%
Survival Outcomes
10%
Ca2+
10%
Deimination
9%
Total RNA
9%
L. Maculans
9%
Centrifugal Microfluidics
9%
Drug Resistance
9%
Medicine and Dentistry
Prostate Cancer
63%
Cystectomy
62%
Bladder Cancer
51%
Malignant Neoplasm
41%
Systematic Review
40%
Prostatectomy
31%
Muscle Invasive Bladder Cancer
30%
Robot-Assisted Prostatectomy
28%
Biological Marker
27%
Neoadjuvant Chemotherapy
27%
Infection
26%
Disease
25%
Exosome
25%
Membrane Microparticle
25%
Meta-Analysis
23%
COVID-19
20%
Neoplasm
19%
Biopsy Technique
18%
Diagnosis
17%
Cancer Cell
16%
Cell Membrane
16%
Adenosine Triphosphate
16%
Chemotherapy
16%
Urinary System
15%
Isotopes of Calcium
13%
Pneumoperitoneum
13%
Transurethral Resection
13%
Non Muscle Invasive Bladder Cancer
12%
Bladder
12%
Metastatic Carcinoma
12%
Computer Assisted Tomography
12%
Urology
12%
Protein Arginine Deiminase
12%
Operation Duration
11%
Surgery
10%
Robot-Assisted Surgery
10%
Cancer
10%
Prostate Biopsy
10%
Escherichia coli
10%
Pelvis
10%
Programmed Cell Death
10%
Urinary Tract Cancer
10%
Pandemic
9%
Overall Survival
9%
Surgeon
9%
Surgical Approach
9%
Smoke
9%
Microhematuria
9%
positron emission tomographic scan
9%
Cystoscopy
9%
Insulin Release
8%
Radiation Therapy
8%
Adenocarcinoma
8%
Urinary Tract Infection
8%
Transrectal Ultrasonography
8%
Medicine
8%
Ischemia
8%
Randomized Controlled Trial
8%
Cell Communication
8%
Bladder Tumor
8%
Hazard Ratio
7%
Da Vinci Surgical System
7%
Odds Ratio
7%
Urologic Surgery
7%
Diabetes
7%
Urothelial Cancer
7%
Arm
7%
Tumor Cell
7%
Transitional Cell Carcinoma
7%
Biogenesis
7%
Cisplatin
7%
Surgical Margin
7%
Receptor
7%
Quality of Life
7%
Cancer Specific Survival
7%
Carcinoma in Situ
7%
Gemcitabine
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Urinary Diversion
6%
Continence
6%
Injury
6%
Mediator
6%
Glucose
6%
Invasive Bladder Cancer
6%
Cannabidiol
6%
Erdafitinib
6%
Osteomyelitis
6%
Inguinal Pain
6%
Merkel Cell Polyomavirus
6%
Antisense
6%
Adenosine Diphosphate
6%
Cytokine
6%
Beta Cell
6%
Spinal Muscular Atrophy
6%
Evacuation
6%
Cohort Study
6%
Immunotherapy
6%
Mesenchymal-Epithelial Transition
6%
Membrane Vesicle
6%
Stem Cell
6%